Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2005 1
2006 1
2007 1
2008 1
2009 2
2010 1
2011 3
2012 2
2013 3
2014 2
2015 4
2016 3
2017 4
2018 3
2019 8
2020 19
2021 13
2022 11
2023 20
2024 17
2025 13
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. Among authors: mosnaim g. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
Jackson DJ, Wechsler ME, Jackson DJ, Bernstein D, Korn S, Pfeffer PE, Chen R, Saito J, de Luíz Martinez G, Dymek L, Jacques L, Bird N, Schalkwijk S, Smith D, Howarth P, Pavord ID; SWIFT-1 and SWIFT-2 Investigators; SWIFT-1 Investigators; SWIFT-2 Investigators. Jackson DJ, et al. N Engl J Med. 2024 Dec 19;391(24):2337-2349. doi: 10.1056/NEJMoa2406673. Epub 2024 Sep 9. N Engl J Med. 2024. PMID: 39248309 Clinical Trial.
Asthma in Adults.
Mosnaim G. Mosnaim G. N Engl J Med. 2023 Sep 14;389(11):1023-1031. doi: 10.1056/NEJMcp2304871. N Engl J Med. 2023. PMID: 37703556 Review. No abstract available.
Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.
Rayner DG, Ferri DM, Guyatt GH, O'Byrne PM, Brignardello-Petersen R, Foroutan F, Chipps B, Sumino K, Perry TT, Nyenhuis S, Oppenheimer J, Israel E, Hoyte F, Rivera-Spoljaric K, McCabe E, Rangel S, Shade LE, Press VG, Hall L, Sue-Wah-Sing D, Melendez A, Orr H, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Rayner DG, et al. Among authors: mosnaim g. JAMA. 2025 Jan 14;333(2):143-152. doi: 10.1001/jama.2024.22700. JAMA. 2025. PMID: 39465893 Free PMC article.
Risk managers for the risk managers.
Taylor-Black SA, Mosnaim G, Anagnostou A, Greenhawt M, Shaker M. Taylor-Black SA, et al. Among authors: mosnaim g. Ann Allergy Asthma Immunol. 2025 Oct 10:S1081-1206(25)01235-9. doi: 10.1016/j.anai.2025.10.004. Online ahead of print. Ann Allergy Asthma Immunol. 2025. PMID: 41076073 No abstract available.
Patient-Reported Outcomes in Asthma.
Mosnaim G, Carrasquel M, Snedden M, Oppenheimer J, Lang D, Rathkopf M. Mosnaim G, et al. J Allergy Clin Immunol Pract. 2024 Oct;12(10):2562-2572. doi: 10.1016/j.jaip.2024.04.061. Epub 2024 May 23. J Allergy Clin Immunol Pract. 2024. PMID: 38796101 Review.
Asthma in Adults. Reply.
Mosnaim G. Mosnaim G. N Engl J Med. 2023 Nov 30;389(22):2112-3. doi: 10.1056/NEJMc2312345. N Engl J Med. 2023. PMID: 38048203 No abstract available.
Digital inhalers for asthma management.
Mosnaim G, Rathkopf M. Mosnaim G, et al. Curr Opin Pulm Med. 2024 May 1;30(3):330-335. doi: 10.1097/MCP.0000000000001056. Epub 2024 Feb 21. Curr Opin Pulm Med. 2024. PMID: 38411213 Review.
Work Group Report: COVID-19: Unmasking Telemedicine.
Hare N, Bansal P, Bajowala SS, Abramson SL, Chervinskiy S, Corriel R, Hauswirth DW, Kakumanu S, Mehta R, Rashid Q, Rupp MR, Shih J, Mosnaim GS. Hare N, et al. Among authors: mosnaim gs. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2461-2473.e3. doi: 10.1016/j.jaip.2020.06.038. Epub 2020 Jun 27. J Allergy Clin Immunol Pract. 2020. PMID: 32603900 Free PMC article. Review.
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
Greenhawt M, Dribin TE, Abrams EM, Shaker M, Chu DK, Golden DBK, Akin C, Anagnostou A, ALMuhizi F, Alqurashi W, Arkwright P, Baldwin JL, Banerji A, Bégin P, Ben-Shoshan M, Bernstein J, Bingemann TA, Bindslev-Jensen C, Blumenthal K, Byrne A, Cahill J, Cameron S, Campbell D, Campbell R, Cavender M, Chan ES, Chinthrajah S, Comberiati P, Eastman JJ, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Garvey LH, Grayson MH, Isabwe GAC, Hartog N, Hendron D, Horner CC, Hourihane JO, Iglesia E, Kan M, Kaplan B, Katelaris CH, Kim H, Kelso JM, Khan DA, Lang D, Ledford D, Levin M, Lieberman JA, Loh R, Mack DP, Mazer B, Mody K, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Nathan R, Oppenheimer J, Otani IM, Park M, Pawankar R, Perrett KP, Peter J, Phillips EJ, Picard M, Pitlick M, Ramsey A, Rasmussen TH, Rathkopf MM, Reddy H, Robertson K, Rodriguez Del Rio P, Sample S, Sheshadri A, Sheik J, Sindher SB, Spergel JM, Stone CA, Stukus D, Tang MLK, Tracy JM, Turner PJ, Vander Leek TK, Wallace DV, Wang J, Wasserman S, Weldon D, Wolfson AR, Worm M, Yacoub MR. Greenhawt M, et al. Among authors: mosnaim g. J Allergy Clin Immunol. 2023 Aug;152(2):309-325. doi: 10.1016/j.jaci.2023.05.019. Epub 2023 Jun 7. J Allergy Clin Immunol. 2023. PMID: 37295474 Free PMC article. Review.
115 results